Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[18F]F PET-CT in Patients With Fibrous Dysplasia/McCune-Albright Syndrome.

Wouter van der BruggenDennis VriensMaartje E MeierFrits SmitElizabeth M WinterLioe-Fee de Geus-OeiNatasha M Appelman-Dijkstra

Published in: The Journal of clinical endocrinology and metabolism (2021)

Na[18F]F-PET-CT captured treatment-induced lesional changes which correlated with BTMs and pain reduction. Therefore Na[18F]F-PET-CT can be used as an objective local parameter of response to denosumab treatment in FD/MAS.

Keyphrases

pet ct
positron emission tomography
bone mineral density
chronic pain
drinking water
risk factors
pain management
combination therapy
oxidative stress
body composition
case report
spinal cord
diabetic rats
drug induced
postoperative pain